Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.45B |
| 2 |
Apple
AAPL
|
+$814M |
| 3 |
NVIDIA
NVDA
|
+$700M |
| 4 |
Broadcom
AVGO
|
+$647M |
| 5 |
Shopify
SHOP
|
+$593M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$701M |
| 2 |
Johnson & Johnson
JNJ
|
+$685M |
| 3 |
DFS
Discover Financial Services
DFS
|
+$484M |
| 4 |
Meta Platforms (Facebook)
META
|
+$407M |
| 5 |
HubSpot
HUBS
|
+$394M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.47% |
| 2 | Financials | 12.85% |
| 3 | Industrials | 11.86% |
| 4 | Consumer Discretionary | 10.17% |
| 5 | Healthcare | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Cardlytics
CDLX
$22.4M
| $165K | ﹤0.01% |
10,048
+343
| +4% | +$5.92K |
|
3502
Nkarta
NKTX
$176M
| $165K | ﹤0.01% |
99,297
+29,901
| +43% | +$54.8K |
|
3503
Immersion
IMMR
$257M
| $163K | ﹤0.01% |
20,682
+2,886
| +16% | +$21.5K |
|
3504
Corvus Pharmaceuticals
CRVS
$1.16B
| $162K | ﹤0.01% |
+40,607
| New | +$148K |
|
3505
Western New England Bancorp
WNEB
$276M
| $160K | ﹤0.01% |
+17,330
| New | +$157K |
|
3506
Editas Medicine
EDIT
$432M
| $159K | ﹤0.01% |
72,294
-14,608
| -17% | -$23.9K |
|
3507
Leslie's
LESL
$10.4M
| $159K | ﹤0.01% |
18,925
+1,714
| +10% | +$22.6K |
|
3508
AlTi Global
ALTI
$476M
| $158K | ﹤0.01% |
38,169
+269
| +0.7% | +$928 |
|
|
BCAX
3509
Bicara Therapeutics
BCAX
$1.82B
| $157K | ﹤0.01% |
16,877
+1,962
| +13% | +$23.4K |
|
|
KGEI
3510
Kolibri Global Energy
KGEI
$186M
| $157K | ﹤0.01% |
+22,871
| New | +$157K |
|
|
WDH
3511
Waterdrop
WDH
$359M
| $156K | ﹤0.01% |
+115,319
| New | +$156K |
|
|
BORR
3512
Borr Drilling
BORR
$1.28B
| $155K | ﹤0.01% |
84,527
+1,483
| +2% | +$2.8K |
|
3513
Lightbridge
LTBR
$292M
| $154K | ﹤0.01% |
+11,486
| New | +$127K |
|
3514
Compass Therapeutics
CMPX
$400M
| $153K | ﹤0.01% |
58,735
+21,578
| +58% | +$44.5K |
|
3515
UNIFI
UFI
$129M
| $153K | ﹤0.01% |
29,219
-16,705
| -36% | -$82.3K |
|
3516
Coherus Oncology
CHRS
$192M
| $152K | ﹤0.01% |
208,271
+21,550
| +12% | +$18.6K |
|
3517
Bioventus
BVS
$1.17B
| $152K | ﹤0.01% |
22,982
-245,046
| -91% | -$1.74M |
|
3518
Information Services Group
III
$251M
| $151K | ﹤0.01% |
31,371
+10,825
| +53% | +$46.6K |
|
3519
Entrada Therapeutics
TRDA
$271M
| $150K | ﹤0.01% |
22,393
+5,702
| +34% | +$45.9K |
|
3520
Spire Global
SPIR
$543M
| $150K | ﹤0.01% |
12,623
+2,062
| +20% | +$20.8K |
|
3521
Black Diamond Therapeutics
BDTX
$114M
| $149K | ﹤0.01% |
60,210
+14,221
| +31% | +$27.4K |
|
|
AISP
3522
Airship AI Holdings
AISP
$69.9M
| $148K | ﹤0.01% |
25,090
+932
| +4% | +$4.15K |
|
3523
Blue Ridge Bankshares
BRBS
$334M
| $148K | ﹤0.01% |
+41,142
| New | +$139K |
|
|
RZLV
3524
Rezolve AI
RZLV
$1.1B
| $147K | ﹤0.01% |
+47,774
| New | +$94.1K |
|
3525
American Outdoor Brands
AOUT
$160M
| $147K | ﹤0.01% |
+14,046
| New | +$161K |
|
Similar funds
Invesco's Q2 2025 Portfolio in Review
As of Q2 2025, Invesco held 3,922 positions worth $588B, up 11% from $528B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Invesco's Q2 2025 filing shows 165 new, 1,670 increased, 1,835 reduced and 165 closed positions. Its largest new stake was QXO Inc: 27,561,664 shares worth $594M. The largest sale was UnitedHealth, an estimated $701M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Financials and Industrials.
- Invesco's largest Q2 2025 buy was QXO Inc: 27,561,664 shares worth $594M.
- Invesco added most to Microsoft in Q2 2025, an estimated $1.45B increase.
- Invesco's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $701M.
- Invesco fully exited Discover Financial Services in Q2 2025, selling an estimated $484M.
- Invesco's ten largest holdings make up 20% of its $588B portfolio in Q2 2025.
- Invesco opened 165 new positions and closed 165 in Q2 2025.
- Invesco's portfolio value rose 11% quarter-over-quarter to $588B.
Based on Invesco's 13F filing for Q2 2025, filed 13 Aug 2025.